Electronic patient-reported outcome
Electronic Patient-Reported Outcome (ePRO) is a method of capturing patient's self-reported health status electronically. These outcomes can include symptoms, functional status, and quality of life. ePROs are increasingly being used in clinical trials and healthcare settings to provide a more accurate and reliable measure of patient outcomes.
Overview[edit]
ePROs are typically collected through electronic devices such as smartphones, tablets, or computers. The use of electronic devices allows for real-time data collection and immediate access to patient responses. This can help healthcare providers to monitor patient health and make timely decisions about treatment.
Benefits[edit]
The use of ePROs has several benefits. Firstly, it can improve the accuracy of data collection by reducing the risk of data entry errors. Secondly, it can increase patient engagement by allowing patients to report their health status in their own words. Thirdly, it can facilitate the collection of data in real-time, which can be particularly useful in monitoring chronic conditions.
Challenges[edit]
Despite these benefits, there are also challenges associated with the use of ePROs. These include the need for technical infrastructure and support, the potential for data privacy issues, and the need for training for both patients and healthcare providers.
Future Directions[edit]
As technology continues to evolve, it is likely that the use of ePROs will continue to increase. Future research is needed to explore the potential benefits and challenges of ePROs in different healthcare settings and patient populations.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
